Form 8-K - Current report:
SEC Accession No. 0001437749-20-020986
Filing Date
2020-10-09
Accepted
2020-10-09 16:16:33
Documents
1
Period of Report
2020-10-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20201009_8k.htm 8-K 22593
  Complete submission text file 0001437749-20-020986.txt   24036
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 201233370
SIC: 2834 Pharmaceutical Preparations